PMID- 9884707
OWN - NLM
STAT- MEDLINE
DCOM- 19990125
LR  - 20181201
IS  - 0507-3758 (Print)
IS  - 0507-3758 (Linking)
VI  - 44
IP  - 5
DP  - 1998
TI  - [Clinical evaluation of the effectiveness of radiotherapy in vaginal metastases 
      of uterine cancer].
PG  - 522-5
AB  - The data on 132 patients with metastases of endometrial carcinoma into the vagina 
      (MECV) were analysed. Among the modalities used were complex (remote + contact) 
      and contact radiotherapy with low-, medium- and high dosage. The following 
      radiobiological models were employed to assess tissue response: 
      time-dose-fractionation factor, cumulative radiation effect and linear-quadratic 
      dose effect equation ("extrapolated dose of response"). There was a correlation 
      between five-year survival in radiation-treated patients and metastasis size. 
      Stage of disease proved a major prognostic factor in MECV treatment. Complex 
      radiotherapy was of crucial importance in MECV treatment whatever the size of 
      disseminated tumor. There was no correlation between efficacy of MECV treatment 
      and therapy used to treat primary endometrial carcinoma (surgery, combined or 
      radiotherapy).
FAU - Kanaev, S V
AU  - Kanaev SV
AD  - Prof. N.N. Petrov Research Institute of Oncology, Ministry of Health of the RF, 
      St. Petersburg.
FAU - Turkevich, V G
AU  - Turkevich VG
LA  - rus
PT  - Comparative Study
PT  - Journal Article
TT  - Klinicheskaia otsenka effektivnosti luchevogo lecheniia metastazov raka tela 
      matki vo vlagalishche.
PL  - Russia (Federation)
TA  - Vopr Onkol
JT  - Voprosy onkologii
JID - 0413775
SB  - IM
MH  - Brachytherapy
MH  - Combined Modality Therapy
MH  - Data Interpretation, Statistical
MH  - Dose Fractionation, Radiation
MH  - Evaluation Studies as Topic
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Lymphatic Metastasis
MH  - Radiotherapy Dosage
MH  - Time Factors
MH  - *Uterine Neoplasms/mortality
MH  - Vaginal Neoplasms/mortality/*radiotherapy/secondary/surgery
EDAT- 1999/01/13 00:00
MHDA- 1999/01/13 00:01
CRDT- 1999/01/13 00:00
PHST- 1999/01/13 00:00 [pubmed]
PHST- 1999/01/13 00:01 [medline]
PHST- 1999/01/13 00:00 [entrez]
PST - ppublish
SO  - Vopr Onkol. 1998;44(5):522-5.